Search research articles
Contact Us
Filters
Showing results (51-60 of 182) with videos related to
Page
of 19
Sort By:
The Oncologist
|
February 10, 2017
Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
Monica Ter-Minassian, Sui Zhang, Nichole V Brooks, et al.
Endocrine-Related Cancer
|
June 28, 2012
Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors
Jennifer A Chan, David P Ryan, Andrew X Zhu, et al.
Genes & Development
|
February 3, 2025
Corrigendum: Identification of a PTEN-regulated STAT<sub>3</sub> brain tumor suppressor pathway
Núria de la Iglesia, Genevieve Konopka, Sidharth V Puram, et al.
Cancer
|
March 8, 2017
Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome
Diana D Shi, David P Yuppa, Trevor Dutton, et al.
Stem Cell Reports
|
June 23, 2015
Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes
Carlo Cusulin, Charles Chesnelong, Pinaki Bose, et al.
The Journal of Biological Chemistry
|
December 25, 2014
Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells
Samuel Lawn, Niveditha Krishna, Alexandra Pisklakova, et al.
Journal of Nuclear Medicine Technology
|
August 5, 2018
Guidance on <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division
Amanda Abbott, Christopher G Sakellis, Eric Andersen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 8, 2016
Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas
Claudius Conrad, Onur C Kutlu, Arvind Dasari, et al.
Cancer
|
June 5, 2013
A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor
Jennifer A Chan, Lawrence Blaszkowsky, Keith Stuart, et al.
The Lancet. Oncology
|
May 10, 2015
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
Alexandria T Phan, Daniel M Halperin, Jennifer A Chan, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 182) with videos related to
Sort By:
Page
of 19
The Oncologist
|
February 10, 2017
Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
Monica Ter-Minassian, Sui Zhang, Nichole V Brooks, et al.
Endocrine-Related Cancer
|
June 28, 2012
Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors
Jennifer A Chan, David P Ryan, Andrew X Zhu, et al.
Genes & Development
|
February 3, 2025
Corrigendum: Identification of a PTEN-regulated STAT<sub>3</sub> brain tumor suppressor pathway
Núria de la Iglesia, Genevieve Konopka, Sidharth V Puram, et al.
Cancer
|
March 8, 2017
Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome
Diana D Shi, David P Yuppa, Trevor Dutton, et al.
Stem Cell Reports
|
June 23, 2015
Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes
Carlo Cusulin, Charles Chesnelong, Pinaki Bose, et al.
The Journal of Biological Chemistry
|
December 25, 2014
Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells
Samuel Lawn, Niveditha Krishna, Alexandra Pisklakova, et al.
Journal of Nuclear Medicine Technology
|
August 5, 2018
Guidance on <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division
Amanda Abbott, Christopher G Sakellis, Eric Andersen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 8, 2016
Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas
Claudius Conrad, Onur C Kutlu, Arvind Dasari, et al.
Cancer
|
June 5, 2013
A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor
Jennifer A Chan, Lawrence Blaszkowsky, Keith Stuart, et al.
The Lancet. Oncology
|
May 10, 2015
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
Alexandria T Phan, Daniel M Halperin, Jennifer A Chan, et al.
Page
of 19